Magnetar Financial’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Magnetar Financial’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-267,508	Closed	-$95.5K	–	996
2024 Q4	$95.5K	Buy	+267,508	New	+$109K	﹤0.01%	576
2023 Q3	–	Sell	-620,574	Closed	-$6.41M	–	609
2023 Q2	$6.41M	Sell	620,574 -362,133	-37%	-$3.71M	0.14%	111
2023 Q1	$9.95M	Sell	982,707 -17,293	-2%	-$174K	0.19%	105
2022 Q4	$9.95M	Hold	1,000,000	–	–	0.17%	147
2022 Q3	$9.75M	Buy	1,000,000 +919,400	+1,141%	+$8.97M	0.14%	185
2022 Q2	$783K	Buy	80,600 +62,900	+355%	+$612K	0.01%	1043
2022 Q1	$172K	Buy	+17,700	New	+$172K	﹤0.01%	1074

Other funds holding NKGN

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

UOC

University of Chicago Chicago, Illinois $420M AUM 42.14% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Magnetar Financial's NKGN Position: Q1 2025 in Review

Magnetar Financial sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 267,508 shares — an estimated $95.5K sold.

Magnetar Financial first reported a position in NKGN in Q1 2022 and held it in 7 quarters. The position peaked at $9.95M in Q1 2023. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

Magnetar Financial reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Magnetar Financial sold 267,508 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $95.5K.
Magnetar Financial first reported a position in NKGen Biotech, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Magnetar Financial's NKGen Biotech, Inc. Common Stock position peaked at $9.95M in Q1 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.